Harnessing the Potential of Biosimilars in Retinal Disease Management
home / case-based-roundtable-series / harnessing-the-potential-of-biosimilars-in-retinal-disease-management
Dr Dilsher Dhoot shares his experience of using anti-VEGF biosimilars for managing retinal diseases and presents two patient cases where he achieved significant anatomic improvement by using a ranibizumab biosimilar.
